-
1
-
-
44249125308
-
Ferraretti assisted reproductive technology in europe: Results generated from european registers by eshre
-
Andersen AN, Goossens V Ferraretti. Assisted reproductive technology in Europe: Results generated from European registers by ESHRE. Hum Reprod 2008;23:756-71
-
(2008)
Hum Reprod
, vol.23
, pp. 756-771
-
-
Andersen, A.N.1
Goossens, V.2
-
3
-
-
77953690564
-
Preventing ovarian hyperstimulation syndrome: Guidance for the clinician
-
Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: Guidance for the clinician. Fertil Steril 2010;94:389-400
-
(2010)
Fertil Steril
, vol.94
, pp. 389-400
-
-
Humaidan, P.1
Quartarolo, J.2
Papanikolaou, E.G.3
-
4
-
-
84875368093
-
GnRH agonist triggering: Recent developments
-
Kol S, Humaidan P. GnRH agonist triggering: Recent developments. Reprod Biomed Online 2013;26:226-30
-
(2013)
Reprod Biomed Online
, vol.26
, pp. 226-230
-
-
Kol, S.1
Humaidan, P.2
-
5
-
-
84875617317
-
Clinical relevance for the fact that GnRH antagonists do not down-regulate the GnRH receptor
-
Gordon K, Stegmann BJ. Clinical relevance for the fact that GnRH antagonists do not down-regulate the GnRH receptor. Hum Reprod 2013;28:1144
-
(2013)
Hum Reprod
, vol.28
, pp. 1144
-
-
Gordon, K.1
Stegmann, B.J.2
-
6
-
-
79959507296
-
Gonadotrophinreleasing hormone antagonists for assisted reproductive technology
-
Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophinreleasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011;(5):CD001750
-
(2011)
Cochrane Database Syst Rev
, Issue.5
-
-
Al-Inany, H.G.1
Youssef, M.A.2
Aboulghar, M.3
-
7
-
-
84874111104
-
GnRH agonist versus GnRH antagonist in ovarian stimulation: An ongoing debate
-
Orvieto R, Patrizio P. GnRH agonist versus GnRH antagonist in ovarian stimulation: An ongoing debate. Reprod Biomed Online 2013;26:4-8
-
(2013)
Reprod Biomed Online
, vol.26
, pp. 4-8
-
-
Orvieto, R.1
Patrizio, P.2
-
9
-
-
34548064239
-
Serum anti-Mullerian hormone and FSH: Prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy
-
Nelson SM, Yates RW, Fleming R. Serum anti-Mullerian hormone and FSH: Prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy. Hum Reprod 2007;22:2414-21
-
(2007)
Hum Reprod
, vol.22
, pp. 2414-2421
-
-
Nelson, S.M.1
Yates, R.W.2
Fleming, R.3
-
10
-
-
33750023496
-
Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome
-
Gustofson RL, Segars JH, Larsen FW. Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome. Hum Reprod 2006;11: 2830-7
-
(2006)
Hum Reprod
, vol.11
, pp. 2830-2837
-
-
Gustofson, R.L.1
Segars, J.H.2
Larsen, F.W.3
-
11
-
-
34548762590
-
A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS
-
Aboulgar M. A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS. Reprod Biomed Online, 2007;15:271-279
-
(2007)
Reprod Biomed Online
, vol.15
, pp. 271-279
-
-
Aboulgar, M.1
-
12
-
-
84865759761
-
GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes
-
Hill MJ, Chason RJ, Payson MD, et al. GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes. RBM Online 2012;25:284-91
-
(2012)
RBM Online
, vol.25
, pp. 284-291
-
-
Hill, M.J.1
Chason, R.J.2
Payson, M.D.3
-
13
-
-
79956340012
-
GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: Three case reports
-
e17-9
-
Martínez F, Rodríguez DB, Buxaderas R, et al. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: Three case reports. Fertil Steril 2011;95:2432.e17-9
-
(2011)
Fertil Steril
, vol.95
, pp. 2432
-
-
Martínez, F.1
Rodríguez, D.B.2
Buxaderas, R.3
-
14
-
-
30344470792
-
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
-
Papanikolaou EG, Pozzobon C, Kolibianakis EM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril 2006;85:112-20
-
(2006)
Fertil Steril
, vol.85
, pp. 112-120
-
-
Papanikolaou, E.G.1
Pozzobon, C.2
Kolibianakis, E.M.3
-
15
-
-
84880547545
-
How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes
-
Solé M, Santaló J, Boada M, et al. How does vitrification affect oocyte viability in oocyte donation cycles? A prospective study to compare outcomes achieved with fresh versus vitrified sibling oocytes. Hum Reprod 2013;28:2087-92
-
(2013)
Hum Reprod
, vol.28
, pp. 2087-2092
-
-
Solé, M.1
Santaló, J.2
Boada, M.3
-
16
-
-
2442710204
-
Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: Randomized controlled trial
-
Aboulghar MA, Mansour RT, Serour GI, et al. Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: Randomized controlled trial. Reprod Biomed Online 2004;8:524-27
-
(2004)
Reprod Biomed Online
, vol.8
, pp. 524-527
-
-
Aboulghar, M.A.1
Mansour, R.T.2
Serour, G.I.3
-
17
-
-
84863213788
-
Empty follicle syndrome after gnrha triggering versus hcg triggering in cos
-
Castillo JC, Garcia-Velasco J, Humaidan P. Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS. J Assist Reprod Genet 2012;29:249-53
-
(2012)
J Assist Reprod Genet
, vol.29
, pp. 249-253
-
-
Castillo, J.C.1
Garcia-Velasco, J.2
Humaidan, P.3
-
18
-
-
0030053181
-
Short term pituitary desensitization: Effects of different doses of the gonadotrophinreleasing hormone agonist triptorelin
-
Broekmans FJ, Hompes PG, Lambalk CB, et al. Short term pituitary desensitization: Effects of different doses of the gonadotrophinreleasing hormone agonist triptorelin. Hum Reprod 1996;11:55-60
-
(1996)
Hum Reprod
, vol.11
, pp. 55-60
-
-
Broekmans, F.J.1
Hompes, P.G.2
Lambalk, C.B.3
-
19
-
-
0029077665
-
Comparison between depot leuprorelin and daily buserelin in IVF
-
Porcu E, Filicori M, Dal Prato L, et al. Comparison between depot leuprorelin and daily buserelin in IVF. J Assist Reprod Genet 1995; 12:15-19
-
(1995)
J Assist Reprod Genet
, vol.12
, pp. 15-19
-
-
Porcu, E.1
Filicori, M.2
Dal Prato, L.3
-
20
-
-
84883136841
-
Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: A retrospective multicentre study
-
Iliodromiti S, Blockeel C, Tremellen KP, et al. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: A retrospective multicentre study. Hum Reprod 2013;28:2529-36
-
(2013)
Hum Reprod
, vol.28
, pp. 2529-2536
-
-
Iliodromiti, S.1
Blockeel, C.2
Tremellen, K.P.3
|